Keywords: GlaxoSmithKline, Tyjerb, Tyverb, Trastuzumab, USA, EU

GlaxoSmithKline files for Tykerb/Tyverb with trastuzumab in USA and Europe

Article | 17 February 2012

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday that it has submitted regulatory applications in Europe and the USA related ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in